Latest Trends in Sexual Health Dealmaking in the Biopharma Industry Since 2012 - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Sep 18, 2018--The “Global Sexual Health Partnering 2012-2018: Deal trends, players and financials” report has been added to ResearchAndMarkets.com’s offering.
The Global Sexual Health Partnering 2012-2018: Deal trends, players and financials report provides an understanding and access to the Sexual Health partnering deals and agreements entered into by the world’s leading healthcare companies.
Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor’s product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.
The report takes readers through the comprehensive Sexual Health disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Sexual Health deals.
The report presents financial deal terms values for Sexual Health deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.
Report scopeTrends in Sexual Health dealmaking in the biopharma industry since 2012 Analysis of Sexual Health deal structure Access to headline, upfront, milestone and royalty data The leading Sexual Health deals by value since 2012
Available deals are listed by:Company A-Z Headline value Stage of development at signing Deal component type Specific therapy target
Key Topics Covered:
Chapter 1 - Introduction
Chapter 2 - Trends in Sexual Health dealmaking
Chapter 3 - Financial deal terms for Sexual Health partnering
Chapter 4 - Leading Sexual Health deals and dealmakers
Chapter 5 - Sexual Health contract document directory
Chapter 6 - Sexual Health dealmaking by therapeutic targetFor more information about this report visit https://www.researchandmarkets.com/research/h97gkd/latest_trends_in?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20180918006113/en/
Laura Wood, Senior Manager
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Sexual and Reproductive Health Drugs
INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY PHARMACEUTICAL OTHER HEALTH
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 09/18/2018 05:04 PM/DISC: 09/18/2018 05:04 PM